Programme 2022
8.30 Registration, networking at the exhibition and partnering meetings
8.55 Welcome and introduction
Johan Rockberg, moderator
9.00 Development of a DNA-based vaccine against SARS-CoV-2 – a collaborative effort between academia, healthcare, and industry
Lars Frelin, Associate Professor in Virology, Karolinska Institutet
9.25 How to overcome the challenges and pitfalls of taking a biological from pre-clinical to clinical development
Ola Tuvesson, Head of Development, NorthX Biologics
9.50 IVT RNA vaccine QC and CGT tools
Ossian Saris, Market Specialist - Europe, Agilent Technologies
10.15 Coffee, networking at the exhibition and partnering meetings
11.00 Pathways to speed up product CMC development for the first-in-human clinical trials
Paresh Vadgama, Fellow Scientist, Product Development, Catalent Biologics
11.25 Safe implementation Pre-Use Post-Sterilization Integrity Test (PUPSIT) on final sterilising grade filters in single-use assemblies
Alexandra Guerra, Principal Scientist, Pall Corporation
11.50 Virtual assessment of intestinal absorption of biological molecules
Christel Bergström, Professor in Molecular Pharmaceutics, Uppsala University
12.15 Lunch, networking at the exhibition and partnering meetings
13.10 How Modular & Pod-ular provide key leverage to a successful, rapid scale out deployment
Andrew Dell, President, KeyPlants Inc
13.35 Smart platform for fast development of small-scale integrated continuous downstream processes
Bernt Nilsson, Professor in Chemical Engineering, Lund University
14.00 Process understanding through down-scale modeling
Marie Svensson, Manager New Technology, Pfizer Biotech Sweden
14.25 Coffee, networking at the exhibition and partnering meetings
15.05 GeneNova – platforms for next generation gene therapy biologics
Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology
15.30 Panel discussion: Vaccine platforms, gene therapy and precision health – where are we today and what will we need in the future?
Marie Svensson, Manager New Technology, Pfizer Biotech Sweden
Ola Tuvesson, Head of Development, NorthX Biologics
Ossian Saris, Market Specialst - Europe, Agilent Technologies
Paresh Vadgama, Fellow Scientist, Product Development, Catalent Biologics
15.55 Summary and conclusion
16.00 Drinks & refreshments reception and celebrations for Life Science Sweden’s 20th anniversary